Senior insider sale
Chief Medical Officer at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$519.3K
21.88K shares
What this filing means
WELGUS HOWARD G. plans to sell 21.88K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $519.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 6/17/2026ACC: 0001628280-26-043877
Officer· Chief Medical Officer
Since Jan 2020
21.88K
Shares to sell
$519.3K
Approx. market value
635.00
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
NA
6/4/2026
635.00Total acquired635.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/4/2026 | Restricted Stock Vesting NA | 635.00 | — |
| Total | 635.00 | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
4.10K
Market value
$100.0K
6/15/2026
—Completed
Units to sell
7.14K
Market value
$164.2K
5/1/2026
—Completed
Units to sell
10K
Market value
$238.8K
4/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
635.00
Market value
$16.3K
6/17/2026
Total
Units
21.88K
Value
$519.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/15/2026 | 4.10K | $100.0K | — | Completed |
5/1/2026 | 7.14K | $164.2K | — | Completed |
4/1/2026 | 10K | $238.8K | — | Completed |
| Planned — Approximate Date | ||||
6/17/2026 | 635.00 | $16.3K | NASDAQ | Planned |
| Total | 21.88K | $519.3K | ||